Halozyme Therapeutics
HALO
#2397
Rank
A$9.78 B
Marketcap
$76.90
Share price
1.19%
Change (1 day)
32.77%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): A$0.71 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$0.94 Billion. In 2023 the company made an earning of A$0.55 Billion, an increase over its 2022 earnings that were of A$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.71 B28.91%
2023 A$0.55 B39.94%
2022 A$0.39 B0.16%
2021 A$0.39 B92.2%
2020 A$0.20 B-278.96%
2019 -A$0.12 Billion-9.45%
2018 -A$0.13 Billion-229.51%
2017 A$97.48 M-160.48%
2016 -A$0.17 Billion216.03%
2015 -A$51 Million-52.86%
2014 -A$0.11 Billion-18.09%
2013 -A$0.14 Billion55.88%
2012 -A$84.74 Million169.94%
2011 -A$31.4 Million-63.44%
2010 -A$85.86 Million-7.19%
2009 -A$92.5 Million15.91%
2008 -A$79.81 Million83.89%
2007 -A$43.4 Million78.1%
2006 -A$24.37 Million16%
2005 -A$21.01 Million45.24%
2004 -A$14.47 Million682.42%
2003 -A$1.85 Million1659.12%
2002 -A$0.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$39.61 M-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
A$16.06 B 2,014.28%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.26 B-65.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.98 B 1,346.18%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.72 B 1,443.00%๐Ÿ‡ซ๐Ÿ‡ท France
A$29.10 B 3,731.55%๐Ÿ‡บ๐Ÿ‡ธ USA